tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Ocular Therapeutix price target raised to $29 from $20 at Citizens JMP
PremiumThe FlyOcular Therapeutix price target raised to $29 from $20 at Citizens JMP
8d ago
Ocular Therapeutix’s Strategic Initiatives and Clinical Advancements Drive Buy Rating
Premium
Ratings
Ocular Therapeutix’s Strategic Initiatives and Clinical Advancements Drive Buy Rating
8d ago
Ocular Therapeutix Announces $475M Stock Offering
Premium
Company Announcements
Ocular Therapeutix Announces $475M Stock Offering
9d ago
Promising Developments and Strategic Advancements Support Buy Rating for Ocular Therapeutix
PremiumRatingsPromising Developments and Strategic Advancements Support Buy Rating for Ocular Therapeutix
2M ago
Ocular Therapeutix: Strategic Advancements and Market Potential Drive Buy Rating
Premium
Ratings
Ocular Therapeutix: Strategic Advancements and Market Potential Drive Buy Rating
2M ago
Ocular Therapeutix receives FDA agreement under SPA for trial of AXPAXLI
Premium
The Fly
Ocular Therapeutix receives FDA agreement under SPA for trial of AXPAXLI
2M ago
Ocular Therapeutix reports Q2 EPS (39c), consensus (35c)
PremiumThe FlyOcular Therapeutix reports Q2 EPS (39c), consensus (35c)
2M ago
Ocular Therapeutix sees cash runway into 2028
Premium
The Fly
Ocular Therapeutix sees cash runway into 2028
2M ago
OCUL Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
OCUL Upcoming Earnings Report: What to Expect?
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100